15,284 Shares of Danaher Corporation $DHR Acquired by Parrish Capital LLC

Key Points

• Parrish Capital LLC acquired 15,284 Danaher shares worth approximately $3.4 million, making the stock its sixth-largest holding and representing 2.6% of its portfolio. Institutional investors collectively own 79.05% of Danaher.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $232.50; Goldman Sachs and Guggenheim recently raised their targets to $250.
• Danaher exceeded quarterly expectations with $1.94 in adjusted EPS and $6.26 billion in revenue, while declaring a $0.40 quarterly dividend, equivalent to a 0.7% annualized yield.

Parrish Capital LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 15,284 shares of the conglomerate's stock, valued at approximately $3,386,000. Danaher accounts for about 2.6% of Parrish Capital LLC's portfolio, making the stock its 6th biggest holding.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Main Street Group LTD bought a new position in shares of Danaher during the first quarter worth approximately $25,000. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher in the second quarter valued at approximately $25,000. Hilton Head Capital Partners LLC acquired a new stake in Danaher during the fourth quarter worth approximately $27,000. Clal Insurance Enterprises Holdings Ltd grew its position in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate's stock worth $29,000 after buying an additional 53 shares in the last quarter. Finally, Evolution Wealth Management Inc. raised its holdings in Danaher by 208.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate's stock valued at $29,000 after acquiring an additional 104 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. The Goldman Sachs Group increased their target price on Danaher from $210.00 to $250.00 and gave the stock a "buy" rating in a report on Monday, September 21st. Weiss Ratings upgraded shares of Danaher from a "hold (c-)" rating to a "hold (c)" rating in a research note on Wednesday, September 16th. DZ Bank initiated coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 target price on the stock. Guggenheim upped their price target on shares of Danaher from $200.00 to $250.00 and gave the stock a "buy" rating in a report on Thursday. Finally, Royal Bank Of Canada increased their price target on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $232.50.

Danaher Price Performance

NYSE:DHR traded down $7.25 during trading hours on Thursday, hitting $214.30. The company's stock had a trading volume of 1,632,244 shares, compared to its average volume of 4,456,548. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a fifty day simple moving average of $208.38 and a 200-day simple moving average of $193.37. The company has a market capitalization of $150.65 billion, a P/E ratio of 38.11, a PEG ratio of 2.82 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.77 earnings per share. On average, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher's dividend payout ratio is 28.42%.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.